From USFDA
Cipla has received Establishment Inspection Report (EIR) from the US FDA for its Indore facility indicating formal closure of the US FDA inspection conducted in July/August, 2015.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
